Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW
- PMID: 37169589
- PMCID: PMC10830125
- DOI: 10.3122/jabfm.2022.220331R1
Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW
Abstract
Background: This study estimates reductions in 10-year atherosclerotic cardiovascular disease (ASCVD) risk associated with EvidenceNOW, a multi-state initiative that sought to improve cardiovascular preventive care in the form of (A)spirin prescribing for high-risk patients, (B)lood pressure control for people with hypertension, (C)holesterol management, and (S)moking screening and cessation counseling (ABCS) among small primary care practices by providing supportive interventions such as practice facilitation.
Design: We conducted an analytic modeling study that combined (1) data from 1,278 EvidenceNOW practices collected 2015 to 2017; (2) patient-level information of individuals ages 40 to 79 years who participated in the 2015 to 2016 National Health and Nutrition Examination Survey (n = 1,295); and (3) 10-year ASCVD risk prediction equations.
Measures: The primary outcome measure was 10-year ASCVD risk.
Results: EvidenceNOW practices cared for an estimated 4 million patients ages 40 to 79 who might benefit from ABCS interventions. The average 10-year ASCVD risk of these patients before intervention was 10.11%. Improvements in ABCS due to EvidenceNOW reduced their 10-year ASCVD risk to 10.03% (absolute risk reduction: -0.08, P ≤ .001). This risk reduction would prevent 3,169 ASCVD events over 10 years and avoid $150 million in 90-day direct medical costs.
Conclusion: Small preventive care improvements and associated reductions in absolute ASCVD risk levels can lead to meaningful life-saving benefits at the population level.
Keywords: Cardiology; Cardiovascular Diseases; Nutrition Surveys; Preventive Health Care; Primary Health Care; Quality Improvement.
© Copyright by the American Board of Family Medicine.
Conflict of interest statement
Conflict of interest: The authors have no conflicts of interest to declare.
Figures
Comment in
-
Re: Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW.J Am Board Fam Med. 2024 Jan 5;36(6):1087-1088. doi: 10.3122/jabfm.2023.230230R0. J Am Board Fam Med. 2024. PMID: 38012010 Free PMC article. No abstract available.
Similar articles
-
Primary Care Practices' Ability to Report Electronic Clinical Quality Measures in the EvidenceNOW Southwest Initiative to Improve Heart Health.JAMA Netw Open. 2019 Aug 2;2(8):e198569. doi: 10.1001/jamanetworkopen.2019.8569. JAMA Netw Open. 2019. PMID: 31390033 Free PMC article.
-
A national evaluation of a dissemination and implementation initiative to enhance primary care practice capacity and improve cardiovascular disease care: the ESCALATES study protocol.Implement Sci. 2016 Jun 29;11(1):86. doi: 10.1186/s13012-016-0449-8. Implement Sci. 2016. PMID: 27358078 Free PMC article.
-
Quality of Cardiovascular Disease Care in Small Urban Practices.Ann Fam Med. 2018 Apr;16(Suppl 1):S21-S28. doi: 10.1370/afm.2174. Ann Fam Med. 2018. PMID: 29632222 Free PMC article. Clinical Trial.
-
Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology.Circulation. 2017 Mar 28;135(13):e793-e813. doi: 10.1161/CIR.0000000000000467. Epub 2016 Nov 4. Circulation. 2017. PMID: 27815375 Free PMC article. Review.
-
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews.JAMA Cardiol. 2016 Jun 1;1(3):341-9. doi: 10.1001/jamacardio.2016.0218. JAMA Cardiol. 2016. PMID: 27438118 Free PMC article. Review.
Cited by
-
Polypill versus medication monotherapy in the prevention of cardiovascular diseases in Iran: An economic evaluation study.Health Sci Rep. 2024 Jul 5;7(7):e2240. doi: 10.1002/hsr2.2240. eCollection 2024 Jul. Health Sci Rep. 2024. PMID: 38974330 Free PMC article.
-
What AHRQ Learned While Working to Transform Primary Care.Ann Fam Med. 2024 Mar-Apr;22(2):161-166. doi: 10.1370/afm.3090. Ann Fam Med. 2024. PMID: 38527822 Free PMC article.
-
Re: Estimating the Cardiovascular Disease Risk Reduction of a Quality Improvement Initiative in Primary Care: Findings from EvidenceNOW.J Am Board Fam Med. 2024 Jan 5;36(6):1087-1088. doi: 10.3122/jabfm.2023.230230R0. J Am Board Fam Med. 2024. PMID: 38012010 Free PMC article. No abstract available.
References
-
- Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC, Sorlie P, Stone NJ, Wilson PWF. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. Circulation. 2013;129(25 suppl 2):S49–S73. Available from: 10.1161/01.cir.0000437741.48606.98. - DOI - PubMed
-
- Lloyd-Jones DM, Huffman MD, Karmali KN, Sanghavi DM, Wright JS, Pelser C, Gulati M, Masoudi FA, Goff DC. Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients. Journal of the American College of Cardiology. 2017;69(12):1617–1636, Available from: 10.1016/j.jacc.2016.10.018. - DOI - PMC - PubMed
-
- Byrd RH, Lu P, Nocedal J, Zhu C. A Limited Memory Algorithm for Bound Constrained Optimization. SIAM Journal on Scientific Computing. 1995;16(5):1190–1208. Available from: 10.1137/0916069. - DOI
-
- Benjamin EJ, Muntner P, Alonso A, On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics-2019 update: A report from the American Heart Association. Circulation 2019;139:e56–e528. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical